MyAverix Finance MyAverix Finance

SHE · Healthcare

Nanhua Bio Medicine Co Ltd (000504)

Biotechnology

Nanhua Bio Medicine Co Ltd (000504) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 000504

P/E ratio
18.00

Nanhua Bio Medicine Co Ltd (000504) — FAQ

What is 000504's P/E ratio?

The price-to-earnings (P/E) ratio for Nanhua Bio Medicine Co Ltd (000504) is 18.00 (data as of 2026-03-24).

Does Nanhua Bio Medicine Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Nanhua Bio Medicine Co Ltd (000504). Check the MyAverix Finance app for the latest dividend data.

What sector is Nanhua Bio Medicine Co Ltd in?

Nanhua Bio Medicine Co Ltd (000504) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 000504 listed on?

000504 is listed on SHE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play